Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting Report

Overview and Analysis of the Utility of 1- and 3-Hour 99mTechnetium-Pyrophosphate Planar and SPECT/CT Imaging in the Diagnosis of Transthyretin Cardiac Amyloidosis

Nicholas Link, Matthew Curry and Yitong Fu
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1611;
Nicholas Link
1University of Tennessee Knoxville Knoxville TN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Curry
1University of Tennessee Knoxville Knoxville TN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yitong Fu
2University of TN Medical Center at Knoxville Knoxville TN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1611

Objectives: The use of 99mTechnetium-Pyrophosphate (99mTc-PYP) for the diagnosis of transthyretin cardiac amyloidosis (ATTR) is a relatively new indication for a radiotracer that has been in use for decades. The American Society of Nuclear Cardiology (ASNC) has set forth guidelines for the interpretation of 99mTc-PYP imaging for the evaluation of ATTR, including both 1-hour quantitative and 3-hour semi-quantitative assessments (Tables 1 and 2). However, since introduction of this study at our medical center in October 2018, discrepancies between the 1-hour and 3-hour methods of image assessment have arisen. In this work we provide an overview of the current ASNC guidelines for the diagnosis of ATTR with 99mTc-PYP, review data from our institution and discuss guideline modifications which may optimize diagnostic accuracy and allocation of resources while performing this study.

Methods: 99mTc-PYP imaging was introduced at our medical center in October 2018. Between October 2018 and December 2019, thirty-five patients underwent evaluation for ATTR with 99mTc-PYP imaging. Analysis included 1-hour quantitative comparison of myocardial and contralateral lung radiotracer uptake utilizing planar imaging (H/L ratio), 3-hour semi-quantitative visual comparison of myocardial and rib radiotracer uptake utilizing planar and SPECT imaging, and 3-hour SPECT/CT imaging to assess the presence or absence of radiotracer within the myocardium. Per ASNC guidelines, studies were deemed “positive” or “strongly suggestive” for ATTR with H/L ratio 1.5 or greater (Table 1) or semi-quantitative visual grade of 2 or greater (Table 2). Studies were deemed “equivocal” for ATTR if a semi-quantitative visual score of 1 or H/L ratio 1-1.5 were recorded. Studies were deemed “negative” if a semi-quantitative visual score of 0 or H/CL ratio less than 1 were recorded. Dictated reports of the 35 patients were reviewed and the various methods of analysis were compared. Results: Of the 35 patients evaluated, 10 patients had a 1-hour H/L ratio of 1.5 or greater (28.6%). Of these 10, 1 had a 3-hour planar visual grade of 0, 1 had a visual grade of 1, and 8 had a visual grade of 3, therefore 2/10 had negative semi-quantitative visual grade that contradicts positive H/L value. Further analysis of these 10 patients with H/L greater than 1.5 revealed 7/10 exhibited myocardial radiotracer uptake on SPECT/CT, while 3/10 had no myocardial uptake on SPECT/CT (2 of these 3 represent the patients with a 3-hour visual grade of 1 or 0). Given this data, 30% of the patients with a 1-hour H/L ratio suggestive of ATTR were determined to be false positives given the lack of myocardial uptake seen on SPECT/CT. Of the 25 patients with 1-hour H/L ratios less than 1.5, none were found to have myocardial radiotracer uptake at 3 hours on SPECT/CT. Conclusion: 1-hour 99mTc-PYP planar imaging may be useful for excluding ATTR but cannot be relied upon to accurately diagnose ATTR. Discrepancies between 1-hour and 3-hour imaging are likely caused by cardiac blood pooling in patients with other etiologies of cardiac dysfunction which falsely elevates the 1-hour H/L ratio. We suggest studies with a 1-hour planar imaging H/L ratio less than 1.5 be considered negative for ATTR and the study terminated. Furthermore, we suggest institutions with the capability of SPECT/CT or SPECT imaging rely solely on the 3-hour planar and SPECT/CT or SPECT imaging to diagnose ATTR, with positive studies requiring a semi-quantitative visual grade of 2 or greater and SPECT/CT or SPECT evidence of myocardial radiotracer uptake.

View this table:
  • View inline
  • View popup

Quantifying myocardial 99mTechnetium-Pyrophosphate uptake utilizing 1-hour planar imaging H/L ratio

View this table:
  • View inline
  • View popup

Semi-quantitative Visual Grading of Myocardial 99mTechnetium-Pyrophosphate Uptake Relative to Rib

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Overview and Analysis of the Utility of 1- and 3-Hour 99mTechnetium-Pyrophosphate Planar and SPECT/CT Imaging in the Diagnosis of Transthyretin Cardiac Amyloidosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Overview and Analysis of the Utility of 1- and 3-Hour 99mTechnetium-Pyrophosphate Planar and SPECT/CT Imaging in the Diagnosis of Transthyretin Cardiac Amyloidosis
Nicholas Link, Matthew Curry, Yitong Fu
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1611;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Overview and Analysis of the Utility of 1- and 3-Hour 99mTechnetium-Pyrophosphate Planar and SPECT/CT Imaging in the Diagnosis of Transthyretin Cardiac Amyloidosis
Nicholas Link, Matthew Curry, Yitong Fu
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1611;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Canine PET/CT imaging with 64Cu-nanomedicines
  • Comparison of pulmonary perfusion index using99mTc-MAA SPECTand evaluation indices obtained from right-sided heart catheterization in chronic thromboembolic pulmonary hypertension
  • Comparison between SiPM-based and conventional PMT-based PET scanners in different reconstruction algorithm using ACR phantom
Show more

Clinical Science (Poster Session)

  • Canine PET/CT imaging with 64Cu-nanomedicines
  • Comparison of pulmonary perfusion index using99mTc-MAA SPECTand evaluation indices obtained from right-sided heart catheterization in chronic thromboembolic pulmonary hypertension
  • Comparison between SiPM-based and conventional PMT-based PET scanners in different reconstruction algorithm using ACR phantom
Show more Clinical Science (Poster Session)

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire